SCHEMBL5192208

SCHEMBL5192208

C[C@]1(n2ccc(NO)nc2=O)C[C@H](O)[C@@H](CO)O1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RY6 Q15077 5/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
MTOR P42345 1/20 0.33
MDM2 Q00987 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
ABL1 P00519 1/20 0.32
RIN1 Q13671 1/20 0.32
PDE4D Q08499 1/20 0.31
PDE3A Q14432 1/20 0.31
SLC29A1 Q99808 1/20 0.31
P2RY2 P41231 2/20 0.31
P2RY4 P51582 2/20 0.31
MAPT P10636 1/20 0.30
CDA P32320 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315826 0.84 CA1 (0.39) POLBP2RY2
SCHEMBL992472 0.84 PDE3A (0.46) POLBLMNATHRBMTORMDM2
SCHEMBL6884819 0.81 POLB (0.37) P2RY6POLBLMNATHRBMTOR
SCHEMBL7240457 0.81 PDE4D (0.32) P2RY6POLBLMNATHRBMTOR
SCHEMBL29891526 0.79 LMNA (0.36) P2RY6POLBLMNATHRBMTOR
SCHEMBL5190899 0.74 PDE4D (0.37) P2RY6POLBLMNATHRBMTOR
SCHEMBL438241 0.74 SLC28A1 (0.44) P2RY6SLC29A1P2RY2P2RY4
SCHEMBL29891333 0.72 LMNA (0.34) POLBLMNATHRBMTORMDM2
SCHEMBL29413003 0.72 LMNA (0.33) P2RY6POLBLMNATHRBMTOR
SCHEMBL29875732 0.71 PNP (0.38) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812456-A2 ß-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 2007-08-01 EP disclosed
WO-2006045616-A2 β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2006-05-04 WO disclosed